Linfeng Mao

906 total citations
23 papers, 658 citations indexed

About

Linfeng Mao is a scholar working on Molecular Biology, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Linfeng Mao has authored 23 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Epidemiology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Linfeng Mao's work include Liver Disease Diagnosis and Treatment (4 papers), RNA modifications and cancer (4 papers) and Thyroid Cancer Diagnosis and Treatment (4 papers). Linfeng Mao is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), RNA modifications and cancer (4 papers) and Thyroid Cancer Diagnosis and Treatment (4 papers). Linfeng Mao collaborates with scholars based in China, United Kingdom and Sweden. Linfeng Mao's co-authors include Peng Huang, Shi Chang, Yuehua Hu, Yi Zhang, Mei Long, Huaming Yang, Qian Yang, Aidong Tang, Zihua Chen and Zhikang Chen and has published in prestigious journals such as Nano Letters, ACS Nano and Advanced Functional Materials.

In The Last Decade

Linfeng Mao

21 papers receiving 655 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linfeng Mao China 12 219 149 102 92 84 23 658
Libing Dai China 15 170 0.8× 213 1.4× 79 0.8× 44 0.5× 101 1.2× 31 646
Zhihe Liu China 16 255 1.2× 122 0.8× 123 1.2× 42 0.5× 49 0.6× 28 618
Hanna Hlawaty France 20 318 1.5× 210 1.4× 135 1.3× 33 0.4× 116 1.4× 33 1.0k
Qianmin Ou China 15 252 1.2× 236 1.6× 94 0.9× 16 0.2× 233 2.8× 26 904
Zhengang Zha China 20 341 1.6× 204 1.4× 129 1.3× 42 0.5× 209 2.5× 45 968
Hao Ren China 19 291 1.3× 370 2.5× 116 1.1× 29 0.3× 770 9.2× 42 1.3k
Yifei Fang China 10 77 0.4× 174 1.2× 26 0.3× 10 0.1× 184 2.2× 23 508
Helin Wang China 14 267 1.2× 65 0.4× 111 1.1× 11 0.1× 127 1.5× 47 955
Anne Mari Rokstad Norway 19 245 1.1× 331 2.2× 40 0.4× 66 0.7× 314 3.7× 34 1.2k
Huan‐Tian Zhang China 21 481 2.2× 156 1.0× 117 1.1× 73 0.8× 170 2.0× 40 976

Countries citing papers authored by Linfeng Mao

Since Specialization
Citations

This map shows the geographic impact of Linfeng Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linfeng Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linfeng Mao more than expected).

Fields of papers citing papers by Linfeng Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linfeng Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linfeng Mao. The network helps show where Linfeng Mao may publish in the future.

Co-authorship network of co-authors of Linfeng Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Linfeng Mao. A scholar is included among the top collaborators of Linfeng Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linfeng Mao. Linfeng Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zheng, Xu, et al.. (2025). O-GlcNAcylation of PRDX1 enhances its stability and promotes liver cancer progression via activating LRP6-mediated Wnt signaling. Cellular Signalling. 135. 112055–112055. 1 indexed citations
3.
4.
Shi, Lin, Liang Chen, Chen Cai, et al.. (2024). The Dynamic Modulation Doping Effect of Gas Molecules on an AlGaN/GaN Heterojunction Surface. Nanomaterials. 14(14). 1211–1211. 2 indexed citations
5.
Xiang, Yuanhang, Linfeng Mao, Yu Yang, et al.. (2024). Buoyant Metal–Organic Framework Corona-Driven Fast Isolation and Ultrasensitive Profiling of Circulating Extracellular Vesicles. ACS Nano. 18(22). 14569–14582. 36 indexed citations
6.
Wang, Ran, Wei Huang, Wuming Zhang, et al.. (2023). FLOT1 promotes gastric cancer progression and metastasis through BCAR1/ERK signaling. International Journal of Biological Sciences. 19(16). 5104–5119. 6 indexed citations
7.
Ma, Yonggang, et al.. (2023). Identification of a novel lncRNA prognostic signature and analysis of functional lncRNA AC115619.1 in hepatocellular carcinoma. Frontiers in Pharmacology. 14. 1167418–1167418. 4 indexed citations
8.
Huang, Peng, Linfeng Mao, Yi Zhang, et al.. (2023). Nanoclay Drug-Delivery System Loading Potassium Iodide Promotes Endocytosis and Targeted Therapy in Anaplastic Thyroid Cancer. Nano Letters. 23(17). 8013–8021. 6 indexed citations
9.
Peng, Ning, Linfeng Mao, Yiwen Tao, et al.. (2022). Callispheres® drug-eluting beads transarterial chemoembolization might be an efficient and safety down-staging therapy in unresectable liver cancer patients. World Journal of Surgical Oncology. 20(1). 254–254. 2 indexed citations
10.
Mao, Linfeng, et al.. (2022). Influence of Hashimoto thyroiditis on diagnosis and treatment of thyroid nodules. Frontiers in Endocrinology. 13. 1067390–1067390. 13 indexed citations
11.
Mao, Linfeng, Changhao Huang, Yi Xu, et al.. (2021). EphA2–YES1–ANXA2 pathway promotes gastric cancer progression and metastasis. Oncogene. 40(20). 3610–3623. 51 indexed citations
12.
Mao, Linfeng, Changhao Huang, Weimin Yang, et al.. (2021). Comprehensive analysis of lncRNA-miRNA-mRNA regulatory networks for microbiota-mediated colorectal cancer associated with immune cell infiltration. Bioengineered. 12(1). 3410–3425. 28 indexed citations
13.
Huang, Changhao, Lai Chen, Shangwei Zhong, et al.. (2019). EphA2‐to‐YAP pathway drives gastric cancer growth and therapy resistance. International Journal of Cancer. 146(7). 1937–1949. 55 indexed citations
14.
Huang, Peng, Linfeng Mao, Zhipeng Zhang, et al.. (2018). Down-Regulated miR-125a-5p Promotes the Reprogramming of Glucose Metabolism and Cell Malignancy by Increasing Levels of CD147 in Thyroid Cancer. Thyroid. 28(5). 613–623. 39 indexed citations
15.
Zhang, Yi, Mei Long, Peng Huang, et al.. (2017). Intercalated 2D nanoclay for emerging drug delivery in cancer therapy. Nano Research. 10(8). 2633–2643. 73 indexed citations
16.
Long, Mei, Yi Zhang, Peng Huang, et al.. (2017). Emerging Nanoclay Composite for Effective Hemostasis. Advanced Functional Materials. 28(10). 176 indexed citations
17.
Zhang, Yi, Mei Long, Peng Huang, et al.. (2016). Emerging integrated nanoclay-facilitated drug delivery system for papillary thyroid cancer therapy. Scientific Reports. 6(1). 33335–33335. 64 indexed citations
18.
Mao, Linfeng, Xu Liu, Xiaolin Jiang, et al.. (2016). [Clinical study on ambulatory surgery for thyroid].. PubMed. 41(3). 305–12. 1 indexed citations
19.
Huang, Peng, et al.. (2015). Bioinformatics analyses of significant prognostic risk markers for thyroid papillary carcinoma. Tumor Biology. 36(10). 7457–7463. 15 indexed citations
20.
Qiu, Jie, Jinwen Zhu, Fei Fu, et al.. (2014). Genome re-sequencing suggested a weedy rice origin from domesticated indica-japonica hybridization: a case study from southern China. Planta. 240(6). 1353–1363. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Libing Dai Breakdown of academic impact, for papers by Zhihe Liu Breakdown of academic impact, for papers by Hanna Hlawaty Breakdown of academic impact, for papers by Qianmin Ou Breakdown of academic impact, for papers by Zhengang Zha Breakdown of academic impact, for papers by Hao Ren Breakdown of academic impact, for papers by Yifei Fang Breakdown of academic impact, for papers by Helin Wang Breakdown of academic impact, for papers by Anne Mari Rokstad Breakdown of academic impact, for papers by Huan‐Tian Zhang
Rankless by CCL
2026